The Pregnant Cardiac Patient: Evaluation and Diagnostic TestingCardiovascular Disease Screening in PregnancySHERMAN-BROWN, ALICE MD; HAMEED, AFSHAN B. MD, FACOG, FACCAuthor Information Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine Professor, Division of Cardiology Medical Director, Obstetrics Medical Director, Quality and Safety, University of California, Irvine, California The authors declare that they have nothing to disclose. Correspondence: Afshan B. Hameed, MD, FACOG, FACC, 333 City Blvd West, Ste 1400, Orange, CA. E-mail: [email protected] Clinical Obstetrics and Gynecology: December 2020 - Volume 63 - Issue 4 - p 808-814 doi: 10.1097/GRF.0000000000000565 Buy Metrics Abstract Cardiovascular disease (CVD) has surpassed the traditional causes of pregnancy-related mortality, including hemorrhage and thromboembolism in the United States. CVD accounts for ~15.5% of all pregnancy-related deaths. Pregnancy is a “natural cardiovascular stress test” for a woman. The physiological changes in the maternal hemodynamics that are geared to accommodate the growing needs of the fetal-placental unit may also lead to symptoms that are indistinguishable from those of CVD, especially in the third trimester of pregnancy. It is imperative that an obstetric provider is able to differentiate symptoms of normal pregnancy from those of a pathologic process. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.